These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19335978)

  • 1. [Dynamic changes of Th1/Th2 type cytokines in peripheral blood of patients with hepatitis B e antigen-positive chronic hepatitis B treated with telbivudine].
    Zhang L; Zhang DZ; Chen M; He H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):175-9. PubMed ID: 19335978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.
    Wang HJ; Jiang YF; Wang XR; Zhang ML; Gao PJ
    World J Gastroenterol; 2016 May; 22(18):4529-37. PubMed ID: 27182162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.
    Ma SW; Huang X; Li YY; Tang LB; Sun XF; Jiang XT; Zhang YX; Sun J; Liu ZH; Abbott WG; Dong YH; Naoumov NV; Hou JL
    J Hepatol; 2012 Apr; 56(4):775-81. PubMed ID: 22173154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the correlation of the effect of entecavir on Th1/Th2 cytokines level in the treatment of chronic hepatitis].
    Li L; Jing YB; Liu J; Wang CL; Liu B
    Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):606-611. PubMed ID: 29056011
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B.
    Piccolo P; Lenci I; di Paolo D; Demelia L; Sorbello O; Nosotti L; Angelico M
    Antivir Ther; 2013; 18(1):57-64. PubMed ID: 22872648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels.
    Lv GC; Ma WJ; Ying LJ; Jin X; Zheng L; Yang YD
    World J Gastroenterol; 2010 Aug; 16(32):4095-9. PubMed ID: 20731026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study.
    Yang X; Li J; Liu J; Gao M; Zhou L; Lu W
    Medicine (Baltimore); 2017 Jun; 96(23):e7064. PubMed ID: 28591041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine.
    Zhang Y; Lian JQ; Li Y; Wang JP; Huang CX; Bai XF; Wang JP
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):814-9. PubMed ID: 23406845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1/Th2 type cytokines in hepatitis B patients treated with interferon-alpha.
    Xing T; Zhang L; Lu Q; Hou J; Feng X; Luo K
    Chin Med J (Engl); 2001 Sep; 114(9):921-4. PubMed ID: 11780382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional restoration of CD56
    Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
    Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the efficacy and HBeAg seroconversion related factors of telbivudine and entecavir therapy in HBeAg positive chronic hepatitis B patients].
    Huang J; Chen XP; Chen XF; Chen WL; Chen R; Ma XJ; Luo XD
    Zhonghua Gan Zang Bing Za Zhi; 2011 Mar; 19(3):178-81. PubMed ID: 21586234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictor of effect of interferon-alpha on patients with hepatitis B: Th1/Th2 type cytokines].
    Xing T; Zhang L; Lu Q
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):268-70. PubMed ID: 11798769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telbivudine for the management of chronic hepatitis B virus infection.
    Matthews SJ
    Clin Ther; 2007 Dec; 29(12):2635-53. PubMed ID: 18201580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ; Liu K; Ma YJ; Wang J; Chen EQ; Tang H
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
    Li C; Ji H; Cai Y; Ayana DA; Lv P; Liu M; Jiang Y
    J Interferon Cytokine Res; 2013 Oct; 33(10):612-8. PubMed ID: 23697556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-term results of telbivudine versus entecavir treatments in HBeAg-positive chronic hepatitis B patients in China].
    Shi KQ; Zhang DZ; Guo SH; He H; Wang ZY; Shi XF; Zeng WQ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):641-5. PubMed ID: 18822200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Law ST; Lee MK; Li KK; Mok CK
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):193-8. PubMed ID: 26587867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influences of camel milk on the immune response of chronic hepatitis B patients].
    Saltanat H; Li H; Xu Y; Wang J; Liu F; Geng XH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):431-3. PubMed ID: 19426601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.